Melatonin and the hair follicle

Journal of Pineal Research

Volumn 44, Issue 1, 2008, Pages 1-15

  Fischer, Tobias W ^a   Slominski, Andrzej ^b   Tobin, Desmond J ^c   Paus, Ralf ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Anagen; Apoptosis; Estrogen receptor; Hair cycle; Hair follicle; Hair pigmentation; Melatonin; Melatonin receptor

Indexed keywords

ANDROGEN RECEPTOR; DNA; ESTROGEN RECEPTOR; MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; MESSENGER RNA; RETINOID RELATED ORPHAN RECEPTOR ALPHA; UNCLASSIFIED DRUG;

ALOPECIA; CELL IMMORTALIZATION; CELL PROTECTION; DNA REPAIR; ENZYME ANALYSIS; EPIDERMIS; EPITHELIUM; FIBROBLAST; HAIR FOLLICLE; HAIR GROWTH; HAMSTER; HORMONE SYNTHESIS; HUMAN; KERATINOCYTE; MELANOCYTE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RNA ANALYSIS; SCALP; SHORT SURVEY; SKIN CELL;

ANIMALS; HAIR; HAIR COLOR; HAIR FOLLICLE; HUMANS; MELATONIN; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; RECEPTORS, MELATONIN; SIGNAL TRANSDUCTION;

EID: 36849064776     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2007.00512.x     Document Type: Short Survey

References (197)

1. Arendt J. Melatonin. Clin Endocrinol (Oxf) 1988 29 : 205 229.
2. Lerner AB, Case JD, Takahashi Y. Isolation of melatonin, a pineal factor that lightens melanocytes. J Am Chem Soc 1958 80 : 2587.
3. Slominski A, Tobin DJ, Shibahara S et al. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev 2004 84 : 1155 1228.
4. Slominski A, Wortsman J, Plonka PM et al. Hair follicle pigmentation. J Invest Dermatol 2005 124 : 13 21.
5. Houssay AB, Pazo JH, Epper CE. Effects of the pineal gland upon the hair cycles in mice. J Invest Dermatol 1966 47 : 230 234.
6. Hoffmann K. Photoperiodic effects in the Djungarian hamster: one minute of light during darktime mimics influence of long photoperiods on testicular recrudescence, body weight and pelage colour. Experientia 1979 35 : 1529 1530.
7. Allain D, Rougeot J. Induction of autumn moult in mink (Mustela vison Peale and Beauvois) with melatonin. Reprod Nutr Dev 1980 20 : 197 201.
8. Duncan MJ, Goldman BD, Di Pinto MN et al. Testicular function and pelage color have different critical daylengths in the Djungarian hamster, Phodopus sungorus. Endocrinology 1985 116 : 424 430.
9. Kuderling I, Cedrini MC, Fraschini F et al. Season-dependent effects of melatonin on testes and fur color in mountain hares (Lepus timidus L.). Experientia 1984 40 : 501 502.
10. Paterson AM, Foldes A. Melatonin and farm animals: endogenous rhythms and exogenous applications. J Pineal Res 1994 16 : 167 177.
11. Kobayashi H, Kromminga A, Dunlop TW et al. A role of melatonin in neuroectodermal-mesodermal interactions: the hair follicle synthesizes melatonin and expresses functional melatonin receptors. FASEB J 2005 19 : 1710 1712.
12. Fischer TW, Elsner P. The antioxidative potential of melatonin in the skin. Curr Probl Dermatol 2001 29 : 165 174.
13. Fischer TW, Sweatman TW, Semak I et al. Constitutive and UV-induced metabolism of melatonin in keratinocytes and cell-free systems. FASEB J 2006 20 : 1564 1566.
14. Semak I, Naumova M, Korik E et al. A novel metabolic pathway of melatonin: oxidation by cytochrome C. Biochemistry 2005 44 : 9300 9307.
15. Tan DX, Manchester LC, Hardeland R et al. Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. J Pineal Res 2003 34 : 75 78.
16. Tan DX, Manchester LC, Terron MP et al. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007 42 : 28 42.
17. Tesoriere L, Avellone G, Ceraulo L et al. Oxidation of melatonin by oxoferryl hemoglobin: a mechanistic study. Free Radic Res 2001 35 : 633 642.
18. Slominski A, Wortsman J, Tobin DJ. The cutaneous serotoninergic/ melatoninergic system: securing a place under the sun. FASEB J 2005 19 : 176 194.
19. Rose J, Oldfield J, Stormshak F. Apparent role of melatonin and prolactin in initiating winter fur growth in mink. Gen Comp Endocrinol 1987 65 : 212 215.
20. Webster JR, Suttie JM, Corson ID. Effects of melatonin implants on reproductive seasonality of male red deer (Cervus elaphus). J Reprod Fertil 1991 92 : 1 11.
21. Welch RAS, Gurnsey MP, Betteridge K et al. Goat fibre response to melatonin given in spring in two consecutive years. Proc N Z Soc Anim Prod 1990 50 : 335 338.
22. Nixon AJ, Choy VJ, Parry AL et al. Fiber growth initiation in hair follicles of goats treated with melatonin. J Exp Zool 1993 267 : 47 56.
23. Diaz SF, Torres SM, Nogueira SA et al. The impact of body site, topical melatonin and brushing on hair regrowth after clipping normal Siberian Husky dogs. Vet Dermatol 2006 17 : 45 50.
24. Xiao Y, Forsberg M, Laitinen JT et al. Effects of melatonin implants on winter fur growth and testicular recrudescence in adult male raccoon dogs (Nyctereutes procyonoides). J Pineal Res 1996 20 : 148 156.
25. Fischer TW, Burmeister G, Schmidt HW et al. Melatonin increases anagen hair rate in women with androgenetic alopecia or diffuse alopecia: results of a pilot randomized controlled trial. Br J Dermatol 2004 150 : 341 345.
26. Fischer TW, Fischer A, Knöll B et al. Melatonin in low doses enhances in vitro human hair follicle proliferation and inhibits hair growth in high doses. Arch Derm Res 2000 292 : 147.
27. Slominski A, Pisarchik A, Semak I et al. Serotoninergic and melatoninergic systems are fully expressed in human skin. FASEB J 2002 16 : 896 898.
28. Slominski A, Pisarchik A, Zbytek B et al. Functional activity of serotoninergic and melatoninergic systems expressed in the skin. J Cell Physiol 2003 196 : 144 153.
29. Slominski A, Baker J, Rosano TG et al. Metabolism of serotonin to N-acetylserotonin, melatonin, and 5-methoxytryptamine in hamster skin culture. J Biol Chem 1996 271 : 12281 12286.
30. Slominski A, Fischer TW, Zmijewski MA et al. On the role of melatonin in skin physiology and pathology. Endocrine 2005 27 : 137 148.
31. Hardeland R. Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine 2005 27 : 119 130.
32. Leon J, Acuna-Castroviejo D, Sainz RM et al. Melatonin and mitochondrial function. Life Sci 2004 75 : 765 790.
33. Fischer TW, Scholz G, Knoll B et al. Melatonin suppresses reactive oxygen species induced by UV irradiation in leukocytes. J Pineal Res 2004 37 : 107 112.
34. Fischer TW, Zbytek B, Sayre RM et al. Melatonin increases survival of HaCaT keratinocytes by suppressing UV-induced apoptosis. J Pineal Res 2006 40 : 18 26.
35. Leon J, Acuna-Castroviejo D, Escames G et al. Melatonin mitigates mitochondrial malfunction. J Pineal Res 2005 38 : 1 9.
36. Fischer TW, Zmijewski MA, Wortsman J et al. Melatonin maintains mitochondrial membrane potential and attenuates activation of initiator (casp-9) and effector caspases (casp-3/casp-7) and PARP in UVR-exposed HaCaT keratinocytes. J Pineal Res 2007 In press.
37. Slominski A, Pisarchik A, Johansson O et al. Tryptophan hydroxylase expression in human skin cells. Biochim Biophys Acta 2003 1639 : 80 86.
38. Schallreuter KU, Wood JM, Pittelkow MR et al. Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin. Science 1994 263 : 1444 1446.
39. Hasse S, Gibbons NC, Rokos H et al. Perturbed 6-tetrahydrobiopterin recycling via decreased dihydropteridine reductase in vitiligo: more evidence for H2O2 stress. J Invest Dermatol 2004 122 : 307 313.
40. Hardeland RFB. Ubiquitous melatonin - presence and effects in unicells, plants and animals. Trends Comp Biochem Physiol 1996 2 : 25 45.
41. Coon SL, Roseboom PH, Baler R et al. Pineal serotonin N-acetyltransferase: expression cloning and molecular analysis. Science 1995 270 : 1681 1683.
42. Ganguly S, Coon SL, Klein DC. Control of melatonin synthesis in the mammalian pineal gland: the critical role of serotonin acetylation. Cell Tissue Res 2002 309 : 127 137.
43. Klein DC. Arylalkylamine N-acetyltransferase: 'the Timezyme'. J Biol Chem 2007 282 : 4233 4237.
44. Kema IP, De Vries EG, Muskiet FA. Clinical chemistry of serotonin and metabolites. J Chromatogr B Biomed Sci Appl 2000 747 : 33 48.
45. Lerner AB, Nordlund JJ. Melatonin: clinical pharmacology. J Neural Transm Suppl 1978 13 : 339 347.
46. Ma X, Idle JR, Krausz KW et al. Metabolism of melatonin by human cytochromes p450. Drug Metab Dispos 2005 33 : 489 494.
47. Kopin IJ, Pare CM, Axelrod J et al. 6-Hydroxylation, the major metabolic pathway for melatonin. Biochim Biophys Acta 1960 40 : 377 378.
48. de Almeida EA, Martinez GR, Klitzke CF et al. Oxidation of melatonin by singlet molecular oxygen (O2(1deltag)) produces N1-acetyl-N2-formyl-5- methoxykynurenine. J Pineal Res 2003 35 : 131 137.
49. Almeida EA, Klitzke CF, Martinez GR et al. Synthesis of internal labeled standards of melatonin and its metabolite N1-acetyl-N2-formyl-5- methoxykynuramine for their quantification using an on-line liquid chromatography-electrospray tandem mass spectrometry system. J Pineal Res 2004 36 : 64 71.
50. Hardeland R, Reiter RJ, Poeggeler B et al. The significance of the metabolism of the neurohormone melatonin: antioxidative protection and formation of bioactive substances. Neurosci Biobehav Rev 1993 17 : 347 357.
51. Tan DX, Manchester LC, Burkhardt S et al. N1-acetyl-N2-formyl-5- methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB J 2001 15 : 2294 2296.
52. Ximenes VF, de OSS, Rodrigues MR et al. Superoxide-dependent oxidation of melatonin by myeloperoxidase. J Biol Chem 2005 280 : 38160 38169.
53. Bubenik GA, Smith PS. Circadian and circannual rhythms of melatonin in plasma of male white- tailed deer and the effect of oral administration of melatonin. J Exp Zool 1987 241 : 81 89.
54. Lerchl A, Schlatt S. Influence of photoperiod on pineal melatonin synthesis, fur color, body weight, and reproductive function in the female Djungarian hamster, Phodopus sungorus. Neuroendocrinology 1993 57 : 359 364.
55. Maestroni GJ. The immunotherapeutic potential of melatonin. Expert Opin Investig Drugs 2001 10 : 467 476.
56. Dillon DC, Easley SE, Asch BB et al. Differential expression of high-affinity melatonin receptors (MT1) in normal and malignant human breast tissue. Am J Clin Pathol 2002 118 : 451 458.
57. Karasek M, Carrillo-Vico A, Guerrero JM et al. Expression of melatonin MT(1) and MT(2) receptors, and ROR alpha(1) receptor in transplantable murine colon 38 cancer. Neuroendocrinol Lett 2002 23 (Suppl. 1 55 60.
58. Kadekaro AL, Andrade LNS, Floeter-Winter LM et al. MT-1 melatonin receptor expression increases the antiproliferative effect of melatonin on S-91 murine melanoma cells. J Pineal Res 2004 36 : 204 211.
59. Winczyk K, Pawlikowski M, Guerrero JM et al. Possible involvement of the nuclear RZR/ROR-alpha receptor in the antitumor action of melatonin on murine colon 38 cancer. Tumour Biol 2002 23 : 298 302.
60. Fischer TW, Zmijewski MA, Zbytek B et al. Oncostatic effects of the indole melatonin and expression of its cytosolic and nuclear receptors in cultured human melanoma cell lines. Int J Oncol 2006 29 : 665 672.
61. Bartsch C, Bartsch H, Karasek M. Melatonin in clinical oncology. Neuroendocrinol Lett 2002 23 (Suppl. 1 30 38.
62. Tan DX, Reiter RJ, Manchester LC et al. Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem 2002 2 : 181 197.
63. Tan DX, Chen LD, Poeggeler B et al. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1993 1 : 57 60.
64. Reiter RJ, Tan DX, Poeggeler B et al. Melatonin as a free radical scavenger: implications for aging and age-related diseases. Ann N Y Acad Sci 1994 719 : 1 12.
65. Reiter RJ, Tan DX, Sainz RM et al. Melatonin: reducing the toxicity and increasing the efficacy of drugs. J Pharm Pharmacol 2002 54 : 1299 1321.
66. Slominski A, Chassalerris N, Mazurkiewicz J et al. Murine skin as a target for melatonin bioregulation. Exp Dermatol 1994 3 : 45 50.
67. Nosjean O, Ferro M, Coge F et al. Identification of the melatonin-binding site MT3 as the quinone reductase 2. J Biol Chem 2000 275 : 31311 31317.
68. Dubocovich ML, Masana MI, Iacob S et al. Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor. Naunyn Schmiedebergs Arch Pharmacol 1997 355 : 365 375.
69. Becker-Andre M, Andre E, DeLamarter JF. Identification of nuclear receptor mRNAs by RT-PCR amplification of conserved zinc-finger motif sequences. Biochem Biophys Res Commun 1993 194 : 1371 1379.
70. Dubocovich ML, Yun K, Al-Ghoul WM et al. Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms. FASEB J 1998 12 : 1211 1220.
71. Nosjean O, Nicolas JP, Klupsch F et al. Comparative pharmacological studies of melatonin receptors: MT1, MT2 and MT3/QR2. Tissue distribution of MT3/QR2. Biochem Pharmacol 2001 61 : 1369 1379.
72. Mailliet F, Ferry G, Vella F et al. Characterization of the melatoninergic MT(3) binding site on the NRH:quinone oxidoreductase 2 enzyme. Biochem Pharmacol 2005 71 : 74 88.
73. Mailliet F, Ferry G, Vella F et al. Organs from mice deleted for NRH:quinone oxidoreductase 2 are deprived of the melatonin binding site MT3. FEBS Lett 2004 578 : 116 120.
74. Iskander K, Paquet M, Brayton C et al. Deficiency of NRH:quinone oxidoreductase 2 increases susceptibility to 7,12-dimethylbenz(a)anthracene and benzo(a)pyrene-induced skin carcinogenesis. Cancer Res 2004 64 : 5925 5928.
75. Vella F, Ferry G, Delagrange P et al. NRH:quinone reductase 2: an enzyme of surprises and mysteries. Biochem Pharmacol 2005 71 : 1 12.
76. Carlberg C, Hooft van Huijsduijnen R, Staple JK et al. RZRs, a new family of retinoid-related orphan receptors that function as both monomers and homodimers. Mol Endocrinol 1994 8 : 757 770.
77. Pozo D, Garcia-Maurino S, Guerrero JM et al. mRNA expression of nuclear receptor RZR/RORalpha, melatonin membrane receptor MT, and hydroxindole-O- methyltransferase in different populations of human immune cells. J Pineal Res 2004 37 : 48 54.
78. Steinmayr M, Andre E, Conquet F et al. Staggerer phenotype in retinoid-related orphan receptor alpha-deficient mice. Proc Natl Acad Sci USA 1998 95 : 3960 3965.
79. Tan DX, Manchester LC, Reiter RJ et al. Identification of highly elevated levels of melatonin in bone marrow: its origin and significance. Biochim Biophys Acta 1999 1472 : 206 214.
80. Tan D, Manchester LC, Reiter RJ et al. High physiological levels of melatonin in the bile of mammals. Life Sci 1999 65 : 2523 2529.
81. Skinner DC, Malpaux B. High melatonin concentrations in third ventricular cerebrospinal fluid are not due to Galen vein blood recirculating through the choroid plexus. Endocrinology 1999 140 : 4399 4405.
82. Bubenik GA, Hacker RR, Brown GM et al. Melatonin concentrations in the luminal fluid, mucosa, and muscularis of the bovine and porcine gastrointestinal tract. J Pineal Res 1999 26 : 56 63.
83. Reiter RJ, Tan DX. What constitutes a physiological concentration of melatonin? J Pineal Res 2003 34 : 79 80.
84. Reiter RJ, Tan DX, Maldonado MD. Melatonin as an antioxidant: physiology versus pharmacology. J Pineal Res 2005 39 : 215 216.
85. Itoh MT, Ishizuka B, Kuribayashi Y et al. Melatonin, its precursors, and synthesizing enzyme activities in the human ovary. Mol Hum Reprod 1999 5 : 402 408.
86. Cahill GM, Besharse JC. Light-sensitive melatonin synthesis by Xenopus photoreceptors after destruction of the inner retina. Vis Neurosci 1992 8 : 487 490.
87. Bubenik GA. Localization, physiological significance and possible clinical implication of gastrointestinal melatonin. Biol Signals Recept 2001 10 : 350 366.
88. Bubenik GA. Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci 2002 47 : 2336 2348.
89. Carrillo-Vico A, Calvo JR, Abreu P et al. Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance. FASEB J 2004 18 : 537 539.
90. Fischer T, Wigger-Alberti W, Elsner P. Melatonin in dermatology. Experimental and clinical aspects. Hautarzt 1999 50 : 5 11.
91. Dicks P, Morgan CJ, Morgan PJ et al. The localisation and characterisation of insulin-like growth factor-I receptors and the investigation of melatonin receptors on the hair follicles of seasonal and non-seasonal fibre-producing goats. J Endocrinol 1996 151 : 55 63.
92. Hoffmann R, Niiyama S, Huth A et al. 17alpha-estradiol induces aromatase activity in intact human anagen hair follicles ex vivo. Exp Dermatol 2002 11 : 376 380.
93. Kaufman KD. Androgen metabolism as it affects hair growth in androgenetic alopecia. Dermatol Clin 1996 14 : 697 711.
94. Paus R, Cotsarelis G. The biology of hair follicles. N Engl J Med 1999 341 : 491 497.
95. Moeller H, Koz A, Rodl W et al. Role of the pineal gland in the regulation of prostatic androgen receptors in pubertal and mature rats. Res Exp Med (Berl) 1983 183 : 157 165.
96. Alonso R, Prieto L, Hernandez C et al. Antiandrogenic effects of the pineal gland and melatonin in castrated and intact prepubertal male rats. J Endocrinol 1978 79 : 77 83.
97. Rimler A, Culig Z, Lupowitz Z et al. Nuclear exclusion of the androgen receptor by melatonin. J Steroid Biochem Mol Biol 2002 81 : 77 84.
98. Rimler A, Jockers R, Lupowitz Z et al. Gi and RGS proteins provide biochemical control of androgen receptor nuclear exclusion. J Mol Neurosci 2007 31 : 1 12.
99. Gilad E, Matzkin H, Zisapel N. Interplay between sex steroids and melatonin in regulation of human benign prostate epithelial cell growth. J Clin Endocrinol Metab 1997 82 : 2535 2541.
100. Siu SW, Lau KW, Tam PC et al. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity. Prostate 2002 52 : 106 122.
101. Clemens JW, Jarzynka MJ, Witt-Enderby PA. Down-regulation of mt1 melatonin receptors in rat ovary following estrogen exposure. Life Sci 2001 69 : 27 35.
102. Gonzalez A, Martinez-Campa C, Mediavilla MD et al. Effects of MT1 melatonin receptor overexpression on the aromatase-suppressive effect of melatonin in MCF-7 human breast cancer cells. Oncol Rep 2007 17 : 947 953.
103. Kiefer TL, Lai L, Yuan L et al. Differential regulation of estrogen receptor alpha, glucocorticoid receptor and retinoic acid receptor alpha transcriptional activity by melatonin is mediated via different G proteins. J Pineal Res 2005 38 : 231 239.
104. Del Rio B, Garcia Pedrero JM, Martinez-Campa C et al. Melatonin, an endogenous-specific inhibitor of estrogen receptor alpha via calmodulin. J Biol Chem 2004 279 : 38294 38302.
105. Girgert R, Bartsch C, Hill SM et al. Tracking the elusive antiestrogenic effect of melatonin: a new methodological approach. Neuro Endocrinol Lett 2003 24 : 440 444.
106. Martinez-Campa C, Alonso-Gonzalez C, Mediavilla MD et al. Melatonin inhibits both ER alpha activation and breast cancer cell proliferation induced by a metalloestrogen, cadmium. J Pineal Res 2006 40 : 291 296.
107. Cos S, Martinez-Campa C, Mediavilla MD et al. Melatonin modulates aromatase activity in MCF-7 human breast cancer cells. J Pineal Res 2005 38 : 136 142.
108. Cos S, Gonzalez A, Martinez-Campa C et al. Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions. Cancer Detect Prev 2006 30 : 118 128.
109. Fischer TW, Elsner P. Melatonin: a hormone, drug or cosmeceutical. In : Cosmeceuticals and Active Cosmetics, Vol. 1. Elsner P, Maibach HI, eds. Taylor and Francis Group, Boca Raton, 2005 pp. 413 419.
110. Slominski A, Wortsman J. Neuroendocrinology of the skin. Endocrine Rev 2000 21 : 457 487.
111. Drew JE, Barrett P, Mercer JG et al. Localization of the melatonin-related receptor in the rodent brain and peripheral tissues. J Neuroendocrinol 2001 13 : 453 458.
112. Slominski A, Pisarchik A, Wortsman J. Expression of genes coding melatonin and serotonin receptors in rodent skin. Biochim Biophys Acta 2004 1680 : 67 70.
113. Gaudet SJ, Slominski A, Etminan M et al. Identification and characterization of two isozymic forms of arylamine N-acetyltransferase in Syrian hamster skin. J Invest Dermatol 1993 101 : 660 665.
114. Slominski A, Semak I, Pisarchik A et al. Conversion of L-tryptophan to serotonin and melatonin in human melanoma cells. FEBS Lett 2002 511 : 102 106.
115. Slominski A, Pisarchik A, Semak I et al. Characterization of the serotoninergic system in the C57BL/6 mouse skin. Eur J Biochem 2003 270 : 3335 3344.
116. Roseboom PH, Namboodiri MA, Zimonjic DB et al. Natural melatonin 'knockdown' in C57BL/6J mice: rare mechanism truncates serotonin N-acetyltransferase. Brain Res Mol Brain Res 1998 63 : 189 197.
117. Maurer M, Metz M. The status quo and quo vadis of mast cells. Exp Dermatol 2005 14 : 923 929.
118. Logan A, Weatherhead B. Post-tyrosinase inhibition of melanogenesis by melatonin in hair follicles in vitro. J Invest Dermatol 1980 74 : 47 50.
119. Slominski A, Pruski D. Melatonin inhibits proliferation and melanogenesis in rodent melanoma cells. Exp Cell Res 1993 206 : 189 194.
120. Iyengar B. Melatonin and melanocyte functions. Biol Signals Recept 2000 9 : 260 266.
121. Hipler UC, Fischer TW, Elsner P. HaCaT cell proliferation influenced by melatonin. Skin Pharmacol Appl Skin Physiol 2003 16 : 379 385.
122. Hu DN, Roberts JE. Melatonin inhibits growth of cultured human uveal melanoma cells. Melanoma Res 1997 7 : 27 31.
123. Helton RA, Harrison WA, Kelley K et al. Melatonin interactions with cultured murine B16 melanoma cells. Melanoma Res 1993 3 : 403 413.
124. Lissoni P, Vaghi M, Ardizzoia A et al. A phase II study of chemoneuroimmunotherapy with platinum, subcutaneous low-dose interleukin-2 and the pineal neurohormone melatonin (P.I.M.) as a second-line therapy in metastatic melanoma patients progressing on dacarbazine plus interferon-alpha. In Vivo 2002 16 : 93 96.
125. Gonzalez R, Sanchez A, Ferguson JA et al. Melatonin therapy of advanced human malignant melanoma. Melanoma Res 1990 1 : 237 243.
126. Lissoni P, Malugani F, Malysheva O et al. Neuroimmunotherapy of untreatable metastatic solid tumors with subcutaneous low-dose interleukin-2, melatonin and naltrexone: modulation of interleukin-2-induced antitumor immunity by blocking the opioid system. Neuroendocrinol Lett 2002 23 : 341 344.
127. Yuan L, Collins AR, Dai J et al. MT(1) melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells. Mol Cell Endocrinol 2002 192 : 147 156.
128. Farriol M, Venereo Y, Orta X et al. In vitro effects of melatonin on cell proliferation in a colon adenocarcinoma line. J Appl Toxicol 2000 20 : 21 24.
129. Fischer TW, Scholz G, Knoll B et al. Melatonin reduces UV-induced reactive oxygen species in a dose-dependent manner in IL-3-stimulated leukocytes. J Pineal Res 2001 31 : 39 45.
130. Fischer TW, Scholz G, Knoll B et al. Melatonin suppresses reactive oxygen species in UV-irradiated leukocytes more than vitamin C and trolox. Skin Pharmacol Appl Skin Physiol 2002 15 : 367 373.
131. Bangha E, Elsner P, Kistler GS. Suppression of UV-induced erythema by topical treatment with melatonin (N-acetyl-5-methoxytryptamine). A dose response study. Arch Dermatol Res 1996 288 : 522 526.
132. Dreher F, Gabard B, Schwindt DA et al. Topical melatonin in combination with vitamins E and C protects skin from ultraviolet-induced erythema: a human study in vivo. Br J Dermatol 1998 139 : 332 339.
133. Bangha E, Elsner P, Kistler GS. Suppression of UV-induced erythema by topical treatment with melatonin (N-acetyl-5-methoxytryptamine). Influence of the application time point. Dermatology 1997 195 : 248 252.
134. Botchkarev VA, Botchkareva NV, Peters EM et al. Epithelial growth control by neurotrophins: leads and lessons from the hair follicle. Prog Brain Res 2004 146 : 493 513.
135. Paus R, Peters EM, Eichmuller S et al. Neural mechanisms of hair growth control. J Investig Dermatol Symp Proc 1997 2 : 61 68.
136. Stenn KS, Paus R. Controls of hair follicle cycling. Physiol Rev 2001 81 : 449 494.
137. Arck PC, Slominski A, Theoharides TC et al. Neuroimmunology of stress: skin takes center stage. J Invest Dermatol 2006 126 : 1697 1704.
138. Peters EM, Arck PC, Paus R. Hair growth inhibition by psychoemotional stress: a mouse model for neural mechanisms in hair growth control. Exp Dermatol 2006 15 : 1 13.
139. Peters EM, Stieglitz MG, Liezman C et al. p75 neurotrophin receptor-mediated signaling promotes human hair follicle regression (catagen). Am J Pathol 2006 168 : 221 234.
140. Paus R, Theoharides TC, Arck PC. Neuroimmunoendocrine circuitry of the 'brain-skin connection'. Trends Immunol 2006 27 : 32 39.
141. Slominski A, Zbytek B, Zmijewski M et al. Corticotropin releasing hormone and the skin. Front Biosci 2006 11 : 2230 2248.
142. Foitzik K, Krause K, Nixon AJ et al. Prolactin and its receptor are expressed in murine hair follicle epithelium, show hair cycle-dependent expression, and induce catagen. Am J Pathol 2003 162 : 1611 1621.
143. Foitzik K, Krause K, Conrad F et al. Human scalp hair follicles are both a target and a source of prolactin, which serves as an autocrine and/or paracrine promoter of apoptosis-driven hair follicle regression. Am J Pathol 2006 168 : 748 756.
144. Ohnemus U, Uenalan M, Inzunza J et al. The hair follicle as an estrogen target and source. Endocr Rev 2006 27 : 677 706.
145. Ito N, Ito T, Kromminga A et al. Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal axis and synthesize cortisol. FASEB J 2005 19 : 1332 1334.
146. Ito N, Ito T, Betterman A et al. The human hair bulb is a source and target of CRH. J Invest Dermatol 2004 122 : 235 237.
147. Paus R, Bodo E, Duske U et al. Indications that normal human hair follicles have established a hypothalamic-pituitary-thyroid (HPT) axis. J Invest Dermatol 2006 126 : 104.
148. Bodo E, Kromminga A, Funk W et al. Human hair follicles are an extrarenal source and a nonhematopoietic target of erythropoietin. FASEB J 2007 21 : 3346 3354.
149. Slominski A, Wortsman J, Tuckey RC et al. Differential expression of HPA axis homolog in the skin. Mol Cell Endocrinol 2007 266 : 143 149.
150. Reiter RJ. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev 1991 12 : 151 180.
151. Lincoln GA, Ebling FJ. Effect of constant-release implants of melatonin on seasonal cycles in reproduction, prolactin secretion and moulting in rams. J Reprod Fertil 1985 73 : 241 253.
152. Rust CC, Meyer RK. Hair color, molt, and testis size in male, short-tailed weasels treated with melatonin. Science 1969 165 : 921 922.
153. Webster JR, Barrell GK. Advancement of reproductive activity, seasonal reduction in prolactin secretion and seasonal pelage changes in pubertal red deer hinds (Cervus elaphus) subjected to artificially shortened daily photoperiod or daily melatonin treatments. J Reprod Fertil 1985 73 : 255 260.
154. Allain D, Ravault JP, Panaretto BA et al. Effects of pinealectomy on photoperiodic control of hair follicle activity in the Limousine ram: possible relationship with plasma prolactin levels. J Pineal Res 1986 3 : 25 32.
155. Ibraheem M, Galbraith H, Scaife J et al. Growth of secondary hair follicles of the Cashmere goat in vitro and their response to prolactin and melatonin. J Anat 1994 185 (Pt 1) : 135 142.
156. Ryder ML. Cashmere, Mohair and Other Luxury Animal Fibres for the Breeder and Spinner. Itchen, Southhampton, 1987.
157. Nixon AJ, Ashby MG, Saywell DP et al. Seasonal fiber growth cycles of ferrets (Mustela putorius furo) and long-term effects of melatonin treatment. J Exp Zool 1995 272 : 435 445.
158. Foldes A, Maxwell CA. Effect of pinealectomy and plane of nutrition on wool growth in Merino sheep. J Pineal Res 1993 15 : 27 34.
159. McCloghry E, Foldes A, Hollis D et al. Effects of pinealectomy on wool growth and wool follicle density in merino sheep. J Pineal Res 1992 13 : 139 144.
160. Xiao Y, Forsberg M, Laitinen JT et al. Effects of melatonin implants in spring on testicular regression and moulting in adult male raccoon dogs (Nyctereutes procynoides). J Reprod Fertil 1995 105 : 9 15.
161. Ashley PF, Frank LA, Schmeitzel LP et al. Effect of oral melatonin administration on sex hormone, prolactin, and thyroid hormone concentrations in adult dogs. J Am Vet Med Assoc 1999 215 : 1111 1115.
162. Webster JR, Barrell GK. Advancement of reproductive activity, seasonal reduction in prolactin secretion and seasonal pelage changes in pubertal red deer hinds (Cervus elaphus) subjected to artificially shortened daily photoperiod or daily melatonin treatments. J Reprod Fertil 1985 73 : 255 260.
163. Fischer TW, Greif C, Fluhr JW et al. Percutaneous penetration of topically applied melatonin in a cream and an alcoholic solution. Skin Pharmacol Physiol 2004 17 : 190 194.
164. Bangha E, Lauth D, Kistler GS et al. Daytime serum levels of melatonin after topical application onto the human skin. Skin Pharmacol 1997 10 : 298 302.
165. Tobin DJ, Slominski A, Botchkarev V et al. The fate of hair follicle melanocytes during the hair growth cycle. J Investig Dermatol Symp Proc 1999 4 : 323 332.
166. Paus R, Ito N, Takigawa M et al. The hair follicle and immune privilege. J Investig Dermatol Symp Proc 2003 8 : 188 194.
167. Muller-Rover S, Handjiski B, van der Veen C et al. A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol 2001 117 : 3 15.
168. Plonka P, Plonka B, Paus R. Biophysical monitoring of melanogenesis as a tool for pigment and hair research. Arch Dermatol Res 1995 287 : 687 690.
169. Slominski A, Paus R, Plonka P et al. Melanogenesis during the anagen-catagen-telogen transformation of the murine hair cycle. J Invest Dermatol 1994 102 : 862 869.
170. Slominski A, Paus R. Melanogenesis is coupled to murine anagen: toward new concepts for the role of melanocytes and the regulation of melanogenesis in hair growth. J Invest Dermatol 1993 101 : 90S 97S.
171. Lin JY, Fisher DE. Melanocyte biology and skin pigmentation. Nature 2007 445 : 843 850.
172. Tobin DJ, Hordinsky M, Bernard BA. Hair pigmentation: a research update. J Investig Dermatol Symp Proc 2005 10 : 275 279.
173. Tobin DJ, Paus R. Graying: gerontobiology of the hair follicle pigmentary unit. Exp Gerontol 2001 36 : 29 54.
174. Rousseau K, Kauser S, Pritchard LE et al. Proopiomelanocortin (POMC), the ACTH/melanocortin precursor, is secreted by human epidermal keratinocytes and melanocytes and stimulates melanogenesis. FASEB J 2007 21 : 1844 1856.
175. Tobin DJ, Kauser S. Beta-endorphin: the forgotten hair follicle melanotropin. J Investig Dermatol Symp Proc 2005 10 : 212 216.
176. Thody AJ, Ridley K, Carter RJ et al. Alpha-MSH and coat color changes in the mouse. Peptides 1984 5 : 1031 1036.
177. Tobin DJ, Kauser S. Hair melanocytes as neuro-endocrine sensors - pigments for our imagination. Mol Cell Endocrinol 2005 243 : 1 11.
178. Clive D, Snell RS. Effect of melatonin on mammalian hair color. J Invest Dermatol 1969 53 : 159 162.
179. Axelrod J, Quay WB, Baker PC. Enzymatic synthesis of the skin-lightening agent, melatonin, in amphibians. Nature 1965 208 : 386.
180. Snell RS. Effect of melatonin on mammalian epidermal melanocytes. J Invest Dermatol 1965 44 : 273 275.
181. Klaus SN, Snell RS. The response of mammalian epidermal melanocytes in culture to hormones. J Invest Dermatol 1967 48 : 352 358.
182. Logan A, Weatherhead B. Effects of alpha-melanocyte-stimulating hormone and [8-arginine]-vasotocin upon melanogenesis in hair follicle melanocytes in vitro. J Endocrinol 1981 91 : 501 507.
183. Logan A, Weatherhead B. Pelage color cycles and hair follicle tyrosinase activity in the Siberian hamster. J Invest Dermatol 1978 71 : 295 298.
184. Baydas G, Reiter RJ, Akbulut M et al. Melatonin inhibits neural apoptosis induced by homocysteine in hippocampus of rats via inhibition of cytochrome c translocation and caspase-3 activation and by regulating pro- and anti-apoptotic protein levels. Neuroscience 2005 135 : 879 886.
185. Han YX, Zhang SH, Wang XM et al. Inhibition of mitochondria responsible for the anti-apoptotic effects of melatonin during ischemia-reperfusion. J Zhejiang Univ Sci B 2006 7 : 142 147.
186. Sun FY, Lin X, Mao LZ et al. Neuroprotection by melatonin against ischemic neuronal injury associated with modulation of DNA damage and repair in the rat following a transient cerebral ischemia. J Pineal Res 2002 33 : 48 56.
187. Bodo E, Tobin DJ, Kamenisch et al. Dissecting the impact of chemotherapy on the human hair follicle. Am J Pathol 2007 171 : 1153 1167.
188. Paus R, Handjiski B, Eichmüller S et al. Chemotherapy-induced alopecia in mice. Induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone. Am J Pathol 1994 144 : 719 734.
189. Ohnemus U, Unalan M, Handjiski B et al. Topical estrogen accelerates hair
190. Paus R. Therapeutic strategies for treating hair loss. Drug Disc Ther Strateg 2006 3 : 101 110.
191. Korf HW, Von Gall C. Mice, melatonin and the circadian system. Mol Cell Endocrinol 2006 252 : 57 68.
192. Park YJ, Park JG, Kim SJ et al. Melatonin receptor of a reef fish with lunar-related rhythmicity: cloning and daily variations. J Pineal Res 2006 41 : 166 174.
193. Torres-Farfan C, Rocco V, Monso C et al. Maternal melatonin effects on clock gene expression in a nonhuman primate fetus. Endocrinology 2006 147 : 4618 4626.
194. Bailey MJ, Beremand PD, Hammer R et al. Transcriptional profiling of the chick pineal gland, a photoreceptive circadian oscillator and pacemaker. Mol Endocrinol 2003 17 : 2084 2095.
195. Paus R, Foitzik K. In search of the 'hair cycle clock': a guided tour. Differentiation 2004 72 : 489 511.
196. Mediavilla MD, San Martin M, Sanchez-Barcelo EJ. Melatonin inhibits mammary gland development in female mice. J Pineal Res 1992 13 : 13 19.
197. Sanchez-Barcelo EJ, Mediavilla MD, Tucker HA. Influence of melatonin on mammary gland growth: in vivo and in vitro studies. Proc Soc Exp Biol Med 1990 194 : 103 107.